Table.

Population Demographics of Patients with Stable Corneal Neovascularization Treated with Short-Term Topical Bevacizumab

Patient	Sex	Age (Yrs)	Diagnosis	Dosage	Weeks of Follow-up	Additional Medicationsc
Etiology: HSV/HZOb Keratitis
1	F	50	HSV Keratitis	BID	6	1
2	F	51	HSV Keratitis	BID	24	2
3	F	65	HZO Keratitis	QID	24	2, 3
4	M	40	S/P LASIK, HSV Keratitis	QID	24	2, 4
5	F	57	HSV Keratitis	QID	24	4, 5
6	M	41	HSV Keratitis	QID	6	6
7a	M	66	HZO Keratitis	QID	24	6
8a	M	73	HSV Keratitis	QID	24	1
Etiology: Keratoplasty/Failed Graft
9	F	73	S/P PKP	BID	24	1, 3, 6
10	M	42	Failed PKP	BID	24	1, 7
11	F	75	Failed PKP	QID	24	1, 6
12	M	55	Failed PKP	QID	24	2
13	M	39	Failed PKP	QID	24	2, 3, 6
Etiology: Limbal Stem Cell Deficiency
14	F	41	LSCD	QID	24	1, 6
15	M	39	S/P LASIK, Partial LSCD	BID	24	2, 7
16	F	71	LSCD	QID	24	None
17	M	60	LSCD	QID	24	1
Etiology: Rosacea/Dry Eye
18	M	24	Rosacea, MGD	QID	24	2, 7
Etiology: Pterygium
19	F	48	S/P Pterygium Excision	QID	24	None
Etiology: Corneal Trauma
20a	M	39	Corneal Laceration	QID	24	5

^aIndicates a patient who did not respond to topical bevacizumab treatment.

^bAbbreviations: HSV = herpes simplex virus; HZO = herpes zoster ophthalmicus; LASIK = laser in situ keratomileusis; LSCD = limbal stem cell deficiency; MGD = meibomian gland dysfunction; PKP = penetrating keratoplasty; S/P = status post; BID = 2 times per day; QID = 4 times per day.

^cAdditional Medications: 1 = artificial tears; 2 = topical steroid; 3 = topical antibiotics; 4 = oral antiviral; 5 = topical anti-glaucoma; 6 = topical cyclosporine; 7 = oral antibiotics.